ETF Managers Group, LLC Ocular Therapeutix, Inc Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$13.43 - $19.16 $999,030 - $1.43 Million
-74,388 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$15.82 - $22.11 $230,845 - $322,629
14,592 Added 24.4%
74,388 $1.19 Million
Q4 2020

Feb 16, 2021
BUY
$7.91 - $22.95 $472,986 - $1.37 Million
59,796 New
59,796 $1.22 Million

Others Institutions Holding OCUL

# of Institutions
190
Shares Held
132M
Call Options Held
374K
Put Options Held
179K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $539M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email